{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:32:13Z","timestamp":1793691133993,"version":"4.5.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.eurox.2024.100308","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T05:21:03Z","timestamp":1713676863000},"page":"100308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Perinatal substance use disorder: Examining the impact on adverse pregnancy outcomes"],"prefix":"10.1016","volume":"22","author":[{"given":"Alexandra S.","family":"Ragsdale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Al-Hammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis M.","family":"Loux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabel","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine M.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj R.","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eurox.2024.100308_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107652","article-title":"Treatment for substance use disorders in pregnant women: motivators and barriers","volume":"205","author":"Frazer","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.eurox.2024.100308_bib2","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.wombi.2018.04.001","article-title":"Reasons for substance use continuation and discontinuation during pregnancy: a qualitative study","volume":"32","author":"Latuskie","year":"2019","journal-title":"Women Birth"},{"key":"10.1016\/j.eurox.2024.100308_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108474","article-title":"\u201cA good mother\u201d: impact of motherhood identity on women's substance use and engagement in treatment across the lifespan","volume":"130","author":"Adams","year":"2021","journal-title":"J Subst Abus Treat"},{"key":"10.1016\/j.eurox.2024.100308_bib4","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2022"},{"key":"10.1016\/j.eurox.2024.100308_bib5","series-title":"National Survey of Drug Use and Health (NSDUH) releases","author":"Substance Abuse and Mental Health Services Administration","year":"2020"},{"key":"10.1016\/j.eurox.2024.100308_bib6","first-page":"405","article-title":"Fetal anomalies and long-term effects associated with substance abuse in pregnancy: a literature review","volume":"32","author":"Viteri","year":"2015","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.eurox.2024.100308_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108265","article-title":"Diagnosis and treatment of substance use disorder among pregnant women in three state Medicaid programs from 2013 to 2016","volume":"124","author":"Lynch","year":"2021","journal-title":"J Subst Abus Treat"},{"key":"10.1016\/j.eurox.2024.100308_bib8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10995-016-2190-y","article-title":"The prevalence and impact of substance use disorder and treatment on maternal obstetric experiences and birth outcomes among singleton deliveries in Massachusetts","volume":"21","author":"Kotelchuck","year":"2017","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.eurox.2024.100308_bib9","series-title":"Healthcare cost and utilization project (HCUP). HCUP NIS database documentation","author":"Agency for Healthcare Research and Quality","year":"2022"},{"key":"10.1016\/j.eurox.2024.100308_bib10","unstructured":"Agency for Healthcare Research and Quality. Healthcare cost and utilization project (HCUP). HCUP NIS description of data elements. Rockville, MD: AHRQ; 2008. Available at \u3008www.hcup-us.ahrq.gov\/db\/vars\/h_region\/nisnote.jsp\u3009."},{"key":"10.1016\/j.eurox.2024.100308_bib11","unstructured":"Agency for Healthcare Research and Quality. Healthcare cost and utilization project (HCUP). HCUP NIS description of data elements. Rockville, MD: AHRQ; 2008. Available at: \u3008www.hcup-us.ahrq.gov\/db\/vars\/hosp_bedsize\/nisnote.jsp\u3009."},{"key":"10.1016\/j.eurox.2024.100308_bib12","unstructured":"Agency for Healthcare Research and Quality. Healthcare cost and utilization project (HCUP). HCUP NIS description of data elements. Rockville, MD: AHRQ; 2008. Available at: \u3008www.hcup-us.ahrq.gov\/db\/vars\/hosp_location\/nisnote.jsp\u3009."},{"key":"10.1016\/j.eurox.2024.100308_bib13","unstructured":"Agency for Healthcare Research and Quality. Healthcare cost and utilization project (HCUP). Producing national HCUP estimates \u2013 accessible version. Rockville, MD: AHRQ; 2018. Available at: \u3008www.hcupus.ahrq.gov\/tech_assist\/nationalestimates\/508_course\/508course_2018.jsp\u3009."},{"key":"10.1016\/j.eurox.2024.100308_bib14","series-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2021"},{"key":"10.1016\/j.eurox.2024.100308_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: nonparametric preprocessing for parametric causal inference","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.eurox.2024.100308_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v009.i08","article-title":"Analysis of complex survey samples","volume":"9","author":"Lumley","year":"2004","journal-title":"J Stat Softw"},{"key":"10.1016\/j.eurox.2024.100308_bib17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1479-828X.2005.00379.x","article-title":"Substance use during pregnancy: risk factors and obstetric and perinatal outcomes in South Australia","volume":"45","author":"Kennare","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.eurox.2024.100308_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10550887.2011.642765","article-title":"Substance use during pregnancy and postnatal outcomes","volume":"31","author":"Irner","year":"2012","journal-title":"J Addict Dis"},{"key":"10.1016\/j.eurox.2024.100308_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/10826084.2021.1958851","article-title":"Neonatal outcomes of infants born to pregnant women with substance use disorders: a multilevel analysis of linked data","volume":"57","author":"Oni","year":"2022","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.eurox.2024.100308_bib20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1503\/cmaj.050406","article-title":"Adverse perinatal outcomes associated with homelessness and substance use in pregnancy","volume":"173","author":"Little","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.eurox.2024.100308_bib21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0038-1667291","article-title":"Drug use during pregnancy and its consequences: a nested case control study on severe maternal morbidity","volume":"40","author":"Pereira","year":"2018","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.eurox.2024.100308_bib22","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1080\/14767058.2022.2035713","article-title":"Impact of in utero opioid exposure on newborn outcomes: beyond neonatal opioid withdrawal syndrome","volume":"35","author":"Bailey","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.eurox.2024.100308_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/08897077.2013.804483","article-title":"Alcohol, tobacco, cocaine, and marijuana use: relative contributions to preterm delivery and fetal growth restriction","volume":"35","author":"Janisse","year":"2014","journal-title":"Subst Abus"},{"key":"10.1016\/j.eurox.2024.100308_bib24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1701-2163(16)32511-7","article-title":"Risk of fetal death associated with maternal drug dependence and placental abruption: a population-based study","volume":"29","author":"McDonald","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.eurox.2024.100308_bib25","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0002-9378(94)70303-5","article-title":"The relationship between exposure during pregnancy to cigarette smoking and cocaine use and placenta previa","volume":"170","author":"Handler","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eurox.2024.100308_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0890-6238(01)00136-8","article-title":"Fetal effects of cocaine: an updated meta-analysis","volume":"15","author":"Addis","year":"2001","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.eurox.2024.100308_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.earlhumdev.2011.09.005","article-title":"Association between cocaine abuse in pregnancy and placenta-associated syndromes using propensity score matching approach","volume":"88","author":"Mbah","year":"2012","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.eurox.2024.100308_bib28","doi-asserted-by":"crossref","first-page":"340.e1","DOI":"10.1016\/j.ajog.2010.11.013","article-title":"Knowledge synthesis group on determinants of low birth weight and preterm births. Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses","volume":"204","author":"Gouin","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eurox.2024.100308_bib29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/GRF.0000000000000418","article-title":"Stimulant use in pregnancy: an under-recognized epidemic among pregnant women","volume":"62","author":"Smid","year":"2019","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.eurox.2024.100308_bib30","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1542\/peds.68.4.550","article-title":"Neonatal manifestations of maternal phencyclidine (PCP) abuse","volume":"68","author":"Strauss","year":"1981","journal-title":"Pediatrics"},{"key":"10.1016\/j.eurox.2024.100308_bib31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/GRF.0000000000000417","article-title":"Benzodiazepines in pregnancy","volume":"62","author":"Shyken","year":"2019","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.eurox.2024.100308_bib32","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-050279","article-title":"Opioid use disorder and perinatal outcomes","volume":"148","author":"Piske","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.eurox.2024.100308_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.clp.2013.05.015","article-title":"Chronic opioid use during pregnancy: maternal and fetal implications","volume":"40","author":"Stanhope","year":"2013","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.eurox.2024.100308_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/AOG.0000000000003907","article-title":"Polysubstance use among pregnant women with opioid use disorder in the United States, 2007\u20132016","volume":"136","author":"Jarlenski","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eurox.2024.100308_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.siny.2019.01.011","article-title":"Stimulants: how big is the problem and what are the effects of prenatal exposure?","volume":"24","author":"Wouldes","year":"2019","journal-title":"Semin Fetal Neonat Med"},{"key":"10.1016\/j.eurox.2024.100308_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108236","article-title":"Substance use disorders and risk of severe maternal morbidity in the United States","volume":"216","author":"Jarlenski","year":"2020","journal-title":"Drug Alcohol Depend"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590161324000280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590161324000280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T22:29:57Z","timestamp":1718576997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590161324000280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":36,"alternative-id":["S2590161324000280"],"URL":"https:\/\/doi.org\/10.1016\/j.eurox.2024.100308","relation":{},"ISSN":["2590-1613"],"issn-type":[{"value":"2590-1613","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perinatal substance use disorder: Examining the impact on adverse pregnancy outcomes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eurox.2024.100308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100308"}}